Detalhe da pesquisa
1.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med
; 389(2): 137-147, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272535
2.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423228
3.
Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series.
BMC Cancer
; 24(1): 686, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38840114
4.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med
; 383(10): 931-943, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469185
5.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485464
6.
The structure of the genetic code as an optimal graph clustering problem.
J Math Biol
; 85(1): 9, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838803
7.
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2040-2051, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280635
8.
Influence of pipe material on biofilm microbial communities found in drinking water supply system.
Environ Res
; 196: 110433, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33166536
9.
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study.
Lancet Oncol
; 21(3): 373-386, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027846
10.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 393(10183): 1819-1830, 2019 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955977
11.
Population morbidity in elderly lung cancer patients from Poland with specific trends in elderly women.
Prz Menopauzalny
; 18(3): 161-165, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31975983
12.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Lancet
; 389(10066): 255-265, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979383
13.
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Oncol
; 18(9): 1261-1273, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729154
14.
Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer.
Int J Colorectal Dis
; 32(7): 1057-1060, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405738
15.
Two neoplasms rich in small lymphocytes, B1B2 thymoma and small lymphocytic lymphoma, intermingled in one tumor mass. A case report.
Pol J Pathol
; 68(1): 75-81, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28547984
16.
Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.
Tumour Biol
; 37(2): 2049-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341493
17.
Structure and microbial diversity of biofilms on different pipe materials of a model drinking water distribution systems.
World J Microbiol Biotechnol
; 31(1): 37-47, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25342310
18.
Analysis of treatment results in primary germ cell tumours with mediastinal location: own experience.
Pneumonol Alergol Pol
; 82(2): 116-24, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615195
19.
[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations]. / Rola systemowych metod leczenia u chorych na niedrobnokomórkowego raka pluca i zlosliwego miedzybloniaka oplucnej: uaktualnione zalecenia ekspertów.
Pneumonol Alergol Pol
; 82(2): 133-49, 2014.
Artigo
em Polonês
| MEDLINE | ID: mdl-24615197
20.
Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.
Contemp Oncol (Pozn)
; 18(1): 7-16, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876815